EPO | Erythropoietin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ETNK2 | Ethanolamine kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
EVA1A | Eva-1 homolog A (C. elegans) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
F10 | Coagulation factor X | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
F11 | Coagulation factor XI | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FBP1 | Fructose-1,6-bisphosphatase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
FMO5 | Flavin containing monooxygenase 5 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FST | Follistatin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FUOM | Fucose mutarotase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
G6PC | Glucose-6-phosphatase, catalytic subunit | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GLTPD2 | Glycolipid transfer protein domain containing 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
GLYCTK | Glycerate kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GNMT | Glycine N-methyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GPLD1 | Glycosylphosphatidylinositol specific phospholipase D1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPT | Glutamic-pyruvate transaminase (alanine aminotransferase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GRB14 | Growth factor receptor-bound protein 14 | Predicted intracellular proteins
| | | | | Tissue enhanced |
GSTA1 | Glutathione S-transferase alpha 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GSTA2 | Glutathione S-transferase alpha 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
HBE1 | Hemoglobin, epsilon 1 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HGD | Homogentisate 1,2-dioxygenase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HOGA1 | 4-hydroxy-2-oxoglutarate aldolase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HPN | Hepsin | Cancer-related genes Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HS3ST3B1 | Heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
HYAL1 | Hyaluronoglucosaminidase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL1RAP | Interleukin 1 receptor accessory protein | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL27 | Interleukin 27 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KCNN2 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KLB | Klotho beta | Predicted membrane proteins
| | | | | Tissue enhanced |
KMO | Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LGSN | Lengsin, lens protein with glutamine synthetase domain | Predicted intracellular proteins
| | | | | Tissue enhanced |
LIME1 | Lck interacting transmembrane adaptor 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
LRCOL1 | Leucine rich colipase-like 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
MAMDC4 | MAM domain containing 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
METTL7B | Methyltransferase like 7B | Predicted secreted proteins
| | | | | Tissue enhanced |
MT1B | Metallothionein 1B | Predicted intracellular proteins
| | | | | Tissue enhanced |
NEU4 | Sialidase 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
NR0B2 | Nuclear receptor subfamily 0, group B, member 2 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR1H4 | Nuclear receptor subfamily 1, group H, member 4 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ONECUT1 | One cut homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
OSGIN1 | Oxidative stress induced growth inhibitor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PANK1 | Pantothenate kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PAQR9 | Progestin and adipoQ receptor family member IX | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PCSK6 | Proprotein convertase subtilisin/kexin type 6 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PCSK9 | Proprotein convertase subtilisin/kexin type 9 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |